PRPH
ProPhase Labs, Inc.
Key Financials
Net Income
$-14743000
↑ 72.4%
Operating Income
$-18047000
↑ 53.3%
Gross Profit
$1.4M
↑ 1022.7%
Total Liabilities
$56.4M
↑ 0.9%
Revenue
$4.3M
↓ 35.8%
Total Assets
$59.9M
↓ 5.3%
Cash & Equivalents
$90000.00
↓ 86.7%
Shareholders' Equity
$3.5M
↓ 52.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-Q | 6/30/2026 | View on SEC |
| 10-K | 6/1/2026 | View on SEC |
| NT 10-Q | 5/15/2026 | View on SEC |
| NT 10-K | 3/27/2026 | View on SEC |
| 8-K | 2/13/2026 | View on SEC |
| 8-K | 2/13/2026 | View on SEC |
| 8-K | 1/27/2026 | View on SEC |
| 8-K | 1/23/2026 | View on SEC |
| 8-K | 1/23/2026 | View on SEC |
| 25-NSE | 1/23/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PRPH |
| Company Name | ProPhase Labs, Inc. |
| CIK | 868278 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (215) 345-0919 |